The moderators screen the questions. I have tried in the past and when I inform them it is a Libigel related question like the breast cancer discovery. I have waited but never got called upon. I too have never heard one analyst ask about Libigel.
ANIP does not need investors to growth ecompany anymore. But when MVP and BlackRock want to sell, I am confident that the Libigel story will be public again.
Market Data 
Markets 
AI
